Respiratory Infections Flashcards

(45 cards)

1
Q

Upper Respiratory Tract (URT)

A

-everything above the larynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lower Respiratory Tract (LRT)

A
  • site of bronchitis, bronchiolitis, pneumonia

- everything below the larynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common Pathogens of the nasopharynx

A
  • rhinovirus

- coronavirus (except SARS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oropharynx

A
  • adeno

- EBV-not a typical respiratory virus but is transmitted by respiratory/oral contact route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Larynx-trachea

A

parainfluenzaviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bronchi

A

-influenzaviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bronchioles

A

-respiratory syncytial viruses (RSV), SARS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

alveoli

A

-influenza, parainfluenza, RSV, SARS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LRT pathogens

A

2 major virus families-orthomyxo and paramyxo
Orthomyxo-segmented, H+N surface glycoproteins
paramyxo-HN+F (G+F for RSV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antigenic Shift

A
  • reassortment of genome segments

- primarily bird viruses, humans are accidental host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Major Flu pandemics

A
H1N1-spanish flu: 1918, severe
H2N2-asian flu: 1957, severe
H3N2-hong kong flu: 1968, moderate 
H5N1-hong kong, 1997
H1N1-mexico swine flu, 2009
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antigenic Drift

A

-random mutations affecting antigenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pigs as carrier of flu

A
  • pigs are hosts to both human and avian strains of flu
  • pigs come in contact w/ birds and humans
  • reservoirs for different strains of flu
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Influenza Virus Evolution

A
  • H1N1 (spanish)-arose directly from birds
  • H2N2 (asian-1957)-3 of the RNAs derived from new source, antigenic shift
  • H3N2-(hong kong-1968)-PB1, HA derived from new source
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Avian Influenza Virus

A

1997-H5N1 strain: found in poultry markets and spread to small numbers of humans w/ high mortality
2007-outbreak from southeast asia westward, virus is endemic in birds
H5N1 transmitted inefficiently from birds to humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Human and avian influenza virus

A

flu virus receptors are glycoproteins containing sialic acid

  • human flu virus prefer alpha-2,6 gal linkages b/w sialic acid and galactose
  • avian flu viruses prefer alpha-2,3 gal linkages
  • humans possess alpha 2,6 gal in URT, but alpha 2,3 gal in alveoli
  • 10 consistent aa’s implicated in differentiating birds and humans (none in H)
  • fear that new mutations will lead to increased virulence in humans
  • all H5N1 isolates show no more than 1 of these 10 mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

H1N1 2009 swine flu

A
  • origin in mexico, rapid spread worldwide
  • despite initial rapid spread and virulence, the global epidemic was not severe:
  • vigilant screening
  • voluntary crowd avoidance, quarantines
  • immunization programs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Factors in influenza pathogenesis (4)

A
  • receptor binding (HA and sialic acid)
  • HA proteolytic cleavage
  • virulence/host range aa determinants (esp. HA, PA, PB1, PB2 genes)
  • cytokine storm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HA proteolytic cleavage in flu pathogenesis

A

-cleavage of HA0 to HA1 and HA2 by host protease to activate virus mediated cell fusion
LPA1 (low pathogenic influenza)-proteases localized in respiratory and intestinal organs
HPA1-ubiquitous proteases

20
Q

Cytokine Storm

A
  • potentially fatal immune rxn involving a positive feedback loop b/w cytokines and immune cells
  • highly pathogenic strains trigger higher levels of pro inflammatory cytokines than less pathogenic strains
  • TNF-alpha
  • CCL5 (RANTES)
  • CCL3
  • CCL4
  • CCL2 (MCP-1)
21
Q

Influenza Vaccines (6)

A
  • succesful, formalin inactivated, fertilized egg grown virus trivalent vaccine (A/california/7/2009 H1N1, A/perth/16/ 2009 H3N2, B/Brisbane/60/2008)
  • successful H1N1 immunization program in Canada in 2009
  • live attenuated (nasal) available as of 2003
  • constant surveillance required to detect new strains
  • depends on good growth new strains in embryonated eggs
  • worldwide production-just a few companies in a few countries
22
Q

Immune Modulation of flu

A
  • NS1 (segment 8) has immunomodulatory activities

- antagonism of host immune response

23
Q

Paramyxo Viruses-2 groups

A
  • parainfluenza

- RSV

24
Q

Parainfleunzaviruses (types 1-4)

A
  • types 1-3 major cause of croup (infection of larynx and upper trachea)
  • type 3 assoc. w/ pneumonia and bronchitis
  • type 4 mild upper RT infections
25
Paramyxo C and V proteins in suppression of IFN signalling
- paramyxoviral genome gives rise to multiple mRNAs, one of which is the C/P/V mRNA - polycistronic, leaky scanning, atypical mechanisms to access C and V genes
26
Viral Suppression of IFN-activated signalling
C, V inhibits Jak-1/Tyk-2 C, V, P (Rabies), VP24 (Ebola) inhibits STAT-1-2 -pathway involved in antiviral response
27
Respiratory Syncytial Virus (RSV) (7)
- most children by age 2 yrs have been infected w/ RSV - major LRT pathogen in infants, children, elderly and immunocompromised - generally mild cold like symptoms in adults - A and B subgroups (differ mostly in G protein) - A subgroup more severe - envelope glycoproteins F and G induce neutralizing Ab's - occurs every year like flu, never completely protected even though infected over and over again
28
RSV Envelope Spikes (3)
``` G -attachment -neutralization and protective antigen -antibody decoy (secreted G) -fractalkine mimic -TLR agonist F -fusion and entry -neutralization and protective antigen -TLR4 agonist SH -putative viroporin -inhibits apoptosis ```
29
RSV Nucleocapsid-associated proteins (4)
N-RNA-binding P-phosphorylation L-polymerase -M2-1-Tc processivity factor
30
RSV Inner Envelope Face proteins (1)
M-assembly
31
RSV Regulatory Protein
M2-2 - decreases viral Tc - increases RNA rep.
32
RSV Non-structural Protein
NS1 and NS2 - inhibit type 1 IFN induction - inhibit type 1 IFN signalling - activate P13K and NF-kappaB - inhibit apoptosis - at 3' end of genomic RNA
33
The search for a safe and effective RSV vaccine
- formalin killed vaccine - non protective and worsened the disease - lung inflammation of neutrophils and eosinophils - induced non-neutralizing antibodies - mouse studies show formalin killed RSV vaccine and RSV G protein primes harmful Th2 response w/ eosinophil recruitment - use subunit (F or G protein) or DNA vaccines - aim to stimulate Th1 but not Th2 response
34
Immune Evasive Mechanisms Used by RSV (5)
- interference w/ type I IFN signalling (NS1/2 proteins degrade STAT2, block Tc activation) - interference w/ TNF signalling (SH protein) - tilting Th1/Th2 balance (G protein) - TLR4 interaction/signalling (F protein) - interference w/ leukocyte chemotaxis (G protein CX3CR-binding motif)
35
Chemokine mimicry by RSV G protein
- G protein has chemokine (CX3CL/fractalkine) activity, allowing binding to CX3CR thereby affecting leukocyte trafficking - -> delayed viral clearance, enhanced infectivity of cells
36
RSV and asthma
- correlation b/w severe RSV disease in early childhood and asthma/recurrent wheezing later in life - polymorphisms of TLR4 assoc. w/ susceptibility to RSV infection and later development of asthma
37
Emerging Respiratory Virus Pathogens (4)
- new strains of flu - hantavirus (member of bunyavirus fam) - SARS - MERS
38
Hantavirus Structure
- lipid enveloped virion | - 3 ss (-) RNA segments
39
Hantavirus Pulmonary Syndrome
- transmitted by rodents and their droppings, virus spread to humans via inhalation - acute respiratory distress syndrome (ARDS) - virus remains in interstitial tissue rather than airspaces
40
Hantavirus Pulmonary Syndrome Pathogenesis
- viral antigens within the endothelium of capillaries in various tissues - EM confirms infection of endothelial cells and macrophages in the lungs of HPS patients - disease severity correlates w/ elevated levels of virus specific CD8+ T cells * endothelial cells separate blood vessels from surrounding tissues
41
SARS (coronavirus)
- severe acute respiratory syndrome - 1st outbreak in 2003 - interstitial pneumonia - may be spread from animals (bats, civet cats) to humans
42
Mechanism of Immunopathogenesis in SARS
- hyperactive immunopathological response (cytokine storm) - virus uses ACE2 (angiotensin converting enzyme 2) as receptor, resulting in its downreg - as a result there is accumulation in lung of angiotensin II which is damaging to lung tissue - > fluid accumulation in lung tissue
43
SARS interference w/ host immune functions
- most things target IFN response | - nsp-16 disguises the cap of v mRNA to make look like cell mRNA
44
MERS (coronavirus)
- Middle East Respiratory Syndrome - emerged 2012 in countries in or near arabian peninsula, also spread by air passenger travel - origin unknown
45
RIsks for Severe RSV
- host determined risk factors - early age of infection - viral factors blocking IFN responses and apoptosis - high infectitvity and viral pathogenesis